KAREN ABT: Open Payments
NPI 1144672577 · CAPE GIRARDEAU, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,565 in 63 payments from 26 companies in 2025. Trend: 2023 $1,403 · 2024 $1,477 · 2025 $1,565
Food & beverage: $1,565
| Company | Payments | Amount |
|---|---|---|
| Procept Biorobotics Corporation | 4 | $349 |
| ABBVIE INC. | 9 | $147 |
| Ferring Pharmaceuticals Inc. | 5 | $139 |
| Sumitomo Pharma America, Inc. | 5 | $117 |
| Dendreon Pharmaceuticals LLC | 5 | $103 |
| Astellas Pharma US Inc | 3 | $76 |
| UROGEN PHARMA, INC. | 3 | $72 |
| Janssen Biotech, Inc. | 4 | $72 |
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $59 |
| Novartis Pharmaceuticals Corporation | 2 | $53 |
Products named: AQUABEAM ROBOTIC SYSTEM, ADSTILADRIN, BOTOX, PROVENGE, Xtandi, ERLEADA, ORGOVYX, Nubeqa.
Industry payments across MO — which companies pay providers there.
